Available human information involved melatonin-metabolite or clock-gene measurements without corresponding clinical sleep outcomes
It has gained popularity for promoting tissue repair and reducing inflammation
Specifically, retatrutide simultaneously activates three incretin and metabolic hormone receptors: GLP-1 (glucagon-like peptide-1) receptor promotes insulin secretion, reduces appetite, and slows gastric emptying [8] [9] GIP (glucose-dependent insulinotropic polypeptide) receptor enhances insulin release and may support fat metabolism [11] [12] Glucagon receptor preclinical and early clinical data suggest this may increase energy expenditure and promote hepatic fat breakdown, though glucagon receptor agonism can also raise blood glucose levels and the full implications in humans are still being characterised [5] [6] This triple mechanism of action is hypothesised to produce meaningful reductions in body weight by addressing multiple aspects of metabolic dysfunction
According to research, L-Carnitine has the ability to enhance the insulin action on muscle cells, which helps in keeping glucose levels low
Preclinical studies have shown anti-inflammatory, angiogenic, and wound-healing properties, supporting its potential to reduce localized inflammation and improve blood flow
The short answer: Wegovy has secured Philippine regulatory approval and is being rolled out by Novo Nordisk Philippines , but supply remains tight in early 2026
